Enpistar Tablet 80/5mg

Adult dose

The recommended dosage of this medication is 1 tablet once daily, to be taken with water regardless of meals. It is advisable to take it at the same time every day (e.g., morning). It is recommended to adjust the individual components (telmisartan or amlodipine) before administration, and if blood pressure is not controlled, the following doses should be administered. - 40/5 milligrams: for patients whose blood pressure is not controlled with 5 milligrams of amlodipine or 40 milligrams of telmisartan.

Child dose

Safety and efficacy have not been established in pediatric patients under 18 years of age, so the use of this medication is not recommended.

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should not be used by pregnant women or women who may become pregnant. This medication should not be administered to patients with certain conditions, such as liver impairment, obstructive biliary disease, severe hypotension, cardiogenic shock, and unstable heart failure after acute myocardial infarction. Patients with primary aldosteronism or aortic stenosis, and hypertrophic obstructive cardiomyopathy require special caution when using this medication. As this medication is metabolized by the liver and excreted in bile, dosage adjustment and caution are necessary in patients with impaired liver function. Patients with gastrointestinal disorders may experience gastrointestinal-related side effects, so it should be administered cautiously. In patients with renal function impairment or renal artery hypertension, there is a risk of worsening kidney function or hypotension, necessitating regular blood tests and monitoring. Elderly patients may exhibit sensitive reactions, so dosing should be adjusted slowly with caution. This medication can significantly reduce blood pressure; if hypotensive symptoms occur, the patient should be laid down immediately and receive fluid therapy if necessary. Hyperkalemia may occur, hence, caution is necessary if potassium supplements or medications containing potassium are taken concurrently. This medication can cause drowsiness or dizziness; therefore, caution should be exercised while driving or operating machinery. There may be interactions with other medications, so it is important to inform healthcare providers of any medications currently being taken. Safety and efficacy have not been established in children, so use is not recommended. In case of overdose, severe hypotension and cardiovascular side effects may occur, so appropriate treatment should be sought immediately at a medical facility. When storing this medication, keep it out of reach of children, away from moisture, and take it immediately after opening the package.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This medication is sensitive to light and should be stored in a container that prevents light exposure. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius to avoid damage.

Appearance

It is a double tablet that is oval-shaped and biconvex in appearance, colored white and light gray.

Package unit

30 tablets (10 tablets/PTPX3)